Sanofi, GSK Reach Virus Vaccine Deals With US, EU
Sanofi, GSK reach virus vaccine deals with US, EU
Coronavirus News: US Makes $2.1 Billion Deal With Sanofi And GSK For COVID-19 Vaccine
Sanofi and GSK expect to begin Phase 1/2 trials of a COVID-19 vaccine in September, with Phase 3 clinical trials beginning at the end of 2020.
UK Signs Up For Sanofi-GSK Coronavirus Vaccine
UK signs up for Sanofi-GSK coronavirus vaccine
Pfizer Lifts Forecast, Expecting Return Of Medical Activity
Pfizer lifts forecast, expecting return of medical activity
More news
Pfizer, BioNTech Reach $1.95 Billion Coronavirus Vaccine Deal With US Government
The deal covers 100 million doses to be delivered in early 2021.
Wednesday’s Stock Market Open: US Equities Fall Amid Escalating Tensions Between US And China
US stocks fell on Wednesday after the U.S. ordered the closure of China’s consulate in Houston
Low-Cost COVID-19 Vaccinations May Be Available By Early 2021, Top Vaccine Makers Say
Top executives from Moderna, Johnson & Johnson, Pfizer, Merck and AstraZeneca revealed their objective in a House subcommittee hearing.
Monday’s Stock Market Close: US Equities Move Higher On Promising Vaccines, Amazon Boosts Nasdaq
US stocks rose on Monday as Chevron agreed to buy Noble Energy, the biggest energy merger since the pandemic began.
Coronavirus Treatment: UK Signs Deals For 90 Million Vaccine Doses From Major Producers
The U.K. has so far signed deals that will provide up to 230 million vaccine doses.
Stock Markets Get Boost From Vaccine Hopes
Stock markets get boost from vaccine hopes
Monday’s Stock Market Close: US Equities Finish Mixed In Volatile Trading Session, Erasing Earlier Gains
US stocks closed mixed on Monday as Nasdaq tech rally petered out
Coronavirus Vaccine: FDA Fast-Tracks Two Candidates From Pfizer, BioNTech
The FDA has granted fast-track status to two COVID-19 vaccine candidates, meant to speed them through potential regulatory processes.
Monday’s Stock Market Open: US Equities Rise Despite Record Spike In Covid-19 Infections In Florida
US stocks rose on Monday as the tech sector celebrated a huge merger among chipmakers
Former FDA Commissioner Warns The US South To Expect An 'Extended Plateau' Of Coronavirus Cases
The warning comes as at least seven states have reported single-day records for new coronavirus cases in the last week.
Coronavirus Treatment: Bill Gates Comments On COVID-19 Vaccine Accessibility
Billionaire public health advocate Bill Gates pushed for a system that allows future vaccines for the novel coronavirus to go to those most in need first, not just those with the most wealth.
Stocks Climb On US Jobs Recovery, Vaccine Hope
Stocks climb on US jobs recovery, vaccine hope
What To Know About Pfizer's Coronavirus Vaccine -- Clinical Trial Shows Significant Immune System Response
The vaccine is among 150 currently under evaluation worldwide.
Wednesday’s Stock Market Close: US Equities Mixed Despite Pfizer’s Promising Virus Vaccine, Strong Private Payroll Data
U.S. stocks were mixed on Wednesday as private payrolls rose 2.4 million in June
BioNTech, Pfizer Report Progress In Coronavirus Vaccine Trial
BioNTech, Pfizer report progress in coronavirus vaccine trial
Former FDA Commissioner Scott Gottlieb Says Around 25% of New York City Has 'Probably' Been Infected With Coronavirus
Dr. Scott Gottlieb comments follow a report from Mount Sinai Health System in New York City saying around 19% of the city's population was infected by April 19.
Cough Syrup Recall 2020: Children’s Robitussin, Dimetapp Medicines Recalled Over Overdose Risk
GSK Consumer Healthcare has recalled children's cough syrup because the dosing cups were improperly marked, which could potentially cause an overdose of the medication.
Coronavirus USA: Former FDA Commissioner Says Protests Could Exacerbate Second Wave Of Virus
Protests against racial injustice have taken place across the United States after George Floyd, a 46-year-old African-American, was killed in Minneapolis last month.
Pharma Chiefs See Coronavirus Vaccine By Year-end, But Challenges 'Daunting'
Pharma chiefs see coronavirus vaccine by year-end, but challenges 'daunting'
Coronavirus Vaccine: Drug Companies Rejected Plans To Fast-Track Vaccines In 2017
The world's top drug firms reportedly rejected vaccine proposals aimed at combating pathogens like the coronavirus.
Coronavirus Research: Pharma Companies Pfizer, BioNTech Begin Trials Of Experimental Vaccine
Companies around the world are racing for an effective vaccine for the coronavirus.
US Coronavirus Death Toll Hits 68,570; Ex-FDA Chief Warns 'Persistent Spread' This Year
COVID-19 will continue its untrammeled spread in the United States with former FDA commisisioner Dr. Scott Gottlieb warning of a persistent spread for the year.
Pages
- Promoted in Broadband
- 1
- 2
- 3
- 4
- 5
Editor's pick
-
FDA Alert: Fake Ozempic Found In US Drug Supply Chain
-
Trump Tariff Exemption For Phones, Laptops Only Temporary: POTUS Wants Them 'to Be Built In America'
-
Harvard Sees $2.2 Billion In Funding Frozen After Defying Trump
-
Trump Tariff Rollercoaster Complicates ECB Rate Call
-
Trump Advisor Navarro Looks To Cool Spat With Musk
-
German Archive Where Victims Of The Nazis Come Back To Life
